Centaurus Financial’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,319
Closed -$329K 988
2021
Q3
$329K Buy
2,319
+90
+4% +$13.2K 0.03% 532
2021
Q2
$348K Sell
2,229
-59
-3% -$9.56K 0.03% 526
2021
Q1
$356K Sell
2,288
-495
-18% -$76.7K 0.04% 459
2020
Q4
$416K Buy
2,783
+402
+17% +$56.8K 0.04% 403
2020
Q3
$315K Buy
2,381
+515
+28% +$67.3K 0.04% 364
2020
Q2
$216K Sell
1,866
-4
-0.2% -$461 0.03% 415
2020
Q1
$184K Buy
1,870
+466
+33% +$61.1K 0.04% 360
2019
Q4
$204K Buy
+1,404
New +$194K 0.03% 453
2018
Q3
Sell
-862
Closed -$93K 2081
2018
Q2
$93K Buy
+862
New +$93.8K 0.01% 737

Other funds holding ZBH

Centaurus Financial's ZBH Position: Q4 2021 in Review

Centaurus Financial sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 2,319 shares — an estimated $329K sold.

Centaurus Financial first reported a position in ZBH in Q2 2018 and held it in 9 quarters. The position peaked at $416K in Q4 2020. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

  • Centaurus Financial reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
  • Centaurus Financial sold 2,319 Zimmer Biomet shares in Q4 2021, an estimated $329K.
  • Centaurus Financial first reported a position in Zimmer Biomet in Q2 2018 and held it in 9 quarters.
  • Centaurus Financial's Zimmer Biomet position peaked at $416K in Q4 2020.
  • 998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Centaurus Financial's 13F filing for Q4 2021, filed 1 Feb 2022.